Viking Therapeutics (VKTX) Insider Trading & Ownership $42.25 +0.76 (+1.83%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Viking Therapeutics (NASDAQ:VKTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$81.78 M Get VKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Viking Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VKTX Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Viking Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/8/2024Lawson MacartneyDirectorSell2,000$68.67$137,340.00 10/28/2024Greg ZanteCFOSell131,687$76.61$10,088,541.07 10/25/2024Sarah Kathryn RouanDirectorSell11,000$80.89$889,790.00 9/20/2024Brian LianCEOSell216,130$70.83$15,308,487.90 9/20/2024J Matthew SingletonDirectorSell10,300$69.50$715,850.00 8/21/2024Brian LianCEOSell1,000$69.90$69,900.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/21/2024J Matthew SingletonDirectorSell5,700$69.72$397,404.00 8/19/2024Brian LianCEOSell112,870$65.80$7,426,846.00 8/19/2024J Matthew SingletonDirectorSell16,000$62.22$995,520.00 8/14/2024J Matthew SingletonDirectorSell20,786$57.53$1,195,818.58 7/30/2024Brian LianCEOSell115,859$57.58$6,671,161.22 7/30/2024Marianna ManciniCOOSell18,026$57.13$1,029,825.38 5/3/2024Greg ZanteCFOSell66,756$74.69$4,986,005.64 5/1/2024Marianna ManciniCOOSell281,425$78.66$22,136,890.50 2/8/2024Brian LianCEOSell269,079$26.87$7,230,152.73 2/8/2024Sarah Kathryn RouanDirectorSell25,000$28.05$701,250.00 1/30/2024Brian LianCEOSell35,000$23.95$838,250.00 1/19/2024Sarah Kathryn RouanDirectorSell30,000$23.05$691,500.00 1/4/2024Greg ZanteCFOSell15,000$17.90$268,500.00 (Data available from 1/1/2013 forward) VKTX Insider Trading Activity - Frequently Asked Questions Who is on Viking Therapeutics's Insider Roster? The list of insiders at Viking Therapeutics includes Brian Lian, Charles A Rowland Jr, Greg Zante, J Matthew Singleton, Lawson Macartney, Marianna Mancini, and Sarah Kathryn Rouan. Learn more on insiders at VKTX. What percentage of Viking Therapeutics stock is owned by insiders? 4.70% of Viking Therapeutics stock is owned by insiders. Learn more on VKTX's insider holdings. Which Viking Therapeutics insiders have been selling company stock? The following insiders have sold VKTX shares in the last 24 months: Brian Lian ($45,518,073.55), Charles A Rowland Jr ($1,000,000.00), Greg Zante ($19,290,247.71), J Matthew Singleton ($3,304,592.58), Lawson Macartney ($905,060.00), Marianna Mancini ($24,076,587.88), and Sarah Kathryn Rouan ($2,282,540.00). How much insider selling is happening at Viking Therapeutics? Insiders have sold a total of 2,144,187 Viking Therapeutics shares in the last 24 months for a total of $96,377,101.72 sold. Viking Therapeutics Key ExecutivesDr. Brian Lian Ph.D. (Age 58)President, CEO & Director Compensation: $987.1kMr. Gregory S. Zante (Age 53)Chief Financial Officer Compensation: $655kMs. Marianne Mancini (Age 59)Chief Operating Officer Compensation: $670k1 recent tradesMr. Michael Morneau (Age 59)Vice President of Finance & Administration Compensation: $375.33kDr. Geoffrey E. Barker Ph.D.Senior Vice President of Pharmaceutical Development More Insider Trading Tools from MarketBeat Related Companies TEVA Insider Ownership BGNE Insider Ownership MRNA Insider Ownership VTRS Insider Ownership SMMT Insider Ownership GMAB Insider Ownership SRPT Insider Ownership CTLT Insider Ownership PCVX Insider Ownership ITCI Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:VKTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VKTX Stock Alerts